Clinical Trials on Transplantation, Organ

Total 55789 results

Novartis

Completed

Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant

Kidney Transplantation

Brazil
Pfizer

Completed

Study Investigating Rapamune For Post-Marketing Surveillance

Kidney Transplantation

Korea, Republic of
Astellas Pharma Korea, Inc.

Terminated

A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

Kidney Transplantation

Korea, Republic of
Novartis Pharmaceuticals

Completed

Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients

Heart Transplantation

Germany
Hoffmann-La Roche

Completed

Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation

Kidney Transplantation

United States
Hoffmann-La Roche

Terminated

Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

Heart Transplantation

France, Germany, United States, Australia, Spain, Austria
Hoffmann-La Roche

Completed

An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil (ORANGE)

Kidney Transplantation

Hungary
Hospices Civils de Lyon

Completed

Catalytic Antibodies to Predict Uninvasively Late Transplant Failure (CATAPULT)

Renal Transplantation

France
Hospital do Rim e Hipertensão
Novartis

Completed

Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

Kidney Transplantation

Brazil
Assistance Publique Hopitaux De Marseille

Unknown

Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT)

Lung Transplantation

France
CHU de Reims

Unknown

Contribution of Diffusion MRI in Renal Graft Transplantation

Renal Transplantation

France
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation

Liver Transplantation

China
Hoffmann-La Roche

Completed

Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

Renal Transplantation

France
University of Turin, Italy

Unknown

Pharmacokinetics of Imipenem During Ex Vivo Lung Perfusion (EVLP)

Lung Transplantation

Italy
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

Liver Transplantation

Taiwan
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Kidney Transplantation

United States
Radboud University Medical Center
Hoffmann-La Roche; Astellas Pharma GmbH

Completed

Rituximab for Prevention of Rejection After Renal Transplantation

Kidney Transplantation

Netherlands
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Prediction of Medication Compliance Following Renal Transplantation

Kidney Transplantation

United States
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Predictors and Intervention for Noncompliance

Kidney Transplantation

United States
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Renal Transplantation

Brazil
IRCCS Policlinico S. Matteo

Completed

Rapamycin and Regulatory T Cells in Kidney Transplantation

Kidney Transplantation

Italy
Novartis Pharmaceuticals

Completed

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Liver Transplantation

Germany, Netherlands, Switzerland, Austria
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Completed

Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium

Corneal Transplantation

France
Novartis Pharmaceuticals

Completed

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Renal Transplantation

Switzerland
University of Oslo School of Pharmacy
Rikshospitalet University Hospital

Completed

Computer Guided Doing of Tacrolimus in Renal Transplantation (OPTIMAL)

Renal Transplantation

Norway
Hoffmann-La Roche

Completed

A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

Liver Transplantation

China
Centre Hospitalier Universitaire de Nice

Completed

AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation (AADAPT)

Renal Transplantation

France
Novartis Pharmaceuticals

Completed

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) (IDEALE)

Renal Transplantation

France
Astellas Pharma Inc

Completed

An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

Kidney Transplantation

Netherlands
University Hospital, Rouen

Completed

Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation (EPARGNE)

Kidney Transplantation

France
Novartis

Completed

Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China (REACH)

Kidney Transplantation

China
Novartis Pharmaceuticals

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program (Senator)

Renal Transplantation

Germany
Emory University
Genzyme, a Sanofi Company

Completed

Alteration in Timing of Plerixafor Administration

Autologous Transplantation

United States
Emory University

Terminated

Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept

Cardiac Transplantation

United States
Karen Wood

Completed

Lung Transplant Specimen Repository and Data Registry Protocol

Lung Transplantation

United States
Novartis

Completed

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland, Germany
Astellas Pharma Inc

Completed

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

Kidney Transplantation

United States, Canada
Severance Hospital

Completed

Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation

Kidney Transplantation

Korea, Republic of
University of Turin, Italy

Completed

SI-EVLP Study: STRESS INDEX in Lung Reconditioning

Lung Transplantation

Italy
Novartis Pharmaceuticals

Terminated

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Renal Transplantation

United States
University of Wisconsin, Madison

Completed

MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal

Renal Transplantation

United States
University Hospitals Cleveland Medical Center
Astellas Pharma Global Development, Inc.

Withdrawn

Alefacept in Kidney Transplant Recipients

Kidney Transplantation

United States
The Second Artillery General Hospital
Capital Medical University; Shanghai Changzheng Hospital; Air Force General Hospital... and other collaborators

Completed

Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation (PSIDRTG)

Renal Transplantation

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients

Heart Transplantation

United States, Australia, Argentina, Canada
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
University Medical Center Goettingen

Unknown

An Observational Study to Assess the Effect of Calcineurin Inhibitors on Markers of Transplant Tolerance (OSCITT)

Liver Transplantation

Germany
Nigel E. Drury

Unknown

Pharmacology of Immunosuppressants Following Heart Transplantation

Heart Transplantation

Australia, United Kingdom
Brigham and Women's Hospital
Genzyme, a Sanofi Company

Completed

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

Renal Transplantation

United States
Mayo Clinic
University of Chicago; Immune Tolerance Network (ITN)

Completed

A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation

Transplantation, Liver

United States
Novartis Pharmaceuticals

Completed

Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Renal Transplantation

Germany

3

Subscribe